All News articles – Page 2
View all stories of the same content type.
-
NewsDiabetes drug offers hope for families with rare cancer-causing genetic condition
Metformin could be used to prevent or delay the emergence of cancer in people with Li Fraumeni syndrome, according to Oxford University researchers
-
News
British Medical Association calls for a wide-ranging review of racial bias throughout the health system
Calls for a full appraisal of racial bias in the health service follow a Government review into whether medical devices are equally effective regardless of ethnicity
-
News
NICE publishes new draft recommendations for the management of depression
The draft guidance includes a menu of treatment options for patients with depression to choose from with their healthcare professional
-
News
HRT associated with lower mortality risk in healthy women
A new study found that combined HRT was associated with a lower risk of all-cause mortality in healthy women
-
News
NICE publishes updated guidance on the management of acute heart failure
The guideline includes recommendations on diagnosis, assessment and monitoring, initial pharmacological and nonpharmacological treatment, management after stabilisation, and the use of mechanical devices
-
News
Antibiotic use in Europe fell by 15% last year
Data from the ECDC indicate that the use of antibiotics decreased by over 15% during the COVID-19 pandemic
-
News
New at-home treatment to be made available for spinal muscular atrophy
A new life-changing drug will treat spinal muscular atrophy at home, following a commercial deal made by the NHS
-
News
Is drinking coffee and tea associated with reduced rates of stroke and dementia?
In a prospective cohort study, people who drank two to three cups of coffee or three to five cups of tea per day, or a combination of four to six cups of coffee and tea, had the lowest incidence of stroke or dementia
-
News
Faster testing promised for secondary ICU infections
A recent proof-of-concept study has shown the potential of clinical metagenomics for same-day testing of secondary infections in ICU patients
-
News
GOLD publishes 2022 COPD report
The annual report on the diagnosis, management, and prevention of COPD has been published by GOLD
-
News
NICE publishes guideline on the management of heart valve disease
The new guidance outlines how adults with heart valve disease should be investigated and managed
-
News
COVID-19 fatality rate is five per 100,000 among children in England
In England, five per 100,000 children died from COVID-19 during the first year of the pandemic, but the fatality rate was much greater in children with life-limiting neurodisabilities
-
News
Two new treatments for COVID-19 approved by the EMA
The European Medicines Agency has approved Ronapreve (casirivimab/imdevimab) and Regkirona (regdanvimab) for use against COVID-19
-
News
£375 million to be invested in neurodegenerative disease research
The Government is to invest £375 million to improve understanding and treatment of neurodegenerative diseases
-
News
Breakthrough in predicting risks of late effects in paediatric cancer
University College London study links paediatric cancer with increased illness later in life
-
News
EMA reports latest data on suspected adverse events with COVID-19 vaccines
The European Medicines Agency has published statistics on adverse events associated with COVID-19 vaccines reported in the EU/EEA
-
News
Vaccine boosters give over 90% protection against symptomatic COVID-19 in adults over 50
First UK real-world study by UKHSA shows increased protection against symptomatic COVID-19 infection
-
News
COVID-19 pandemic affecting women’s reproductive health
In a survey conducted in April 2021, women reported disturbances in menstrual cycles and worsening of premenstrual symptoms
-
News
Publicly available defibrillators less common in deprived areas
New research shows that publicly accessible AEDs are not located in the areas that need them most
-
News
NICE updates joint guideline on long COVID
NICE has updated its joint guideline on managing the long-term effects of COVID-19
